Communication Intervention to Improve Influenza Vaccination Rates Among Elderly in Can Tho (NCT07508189) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Communication Intervention to Improve Influenza Vaccination Rates Among Elderly in Can Tho
Vietnam1,200 participantsStarted 2015-09-01
Plain-language summary
This study evaluates the effectiveness of a community-based communication intervention to increase influenza vaccination rates among the elderly (aged above 65) in Can Tho City, Vietnam. Using a cluster randomized controlled trial design, the intervention includes direct counseling, social media engagement (Zalo), and educational materials targeting the elderly, their relatives, and local health workers. The primary goal is to assess changes in vaccination coverage over a 9-month period.
Who can participate
Age range
66 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Residents living in selected wards/communes in Can Tho City for at least 6 months.
* Aged above 65 years.
* Mentally and physically capable of participating in interviews and receiving communication interventions.
* Agree to participate in the study and provide informed consent.
Exclusion Criteria:
* Individuals with severe cognitive impairment or dementia.
* Individuals with contraindications to influenza vaccination.
* Planning to move out of the study area during the 12-month follow-up period.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Influenza Vaccination Coverage Rate
Timeframe: Baseline (Month 0) and Post-intervention (Month 12)
Trial details
NCT IDNCT07508189
SponsorCan Tho University of Medicine and Pharmacy